Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Tumors”

10,308 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 10,308 results

Early research (Phase 1)Not Yet RecruitingNCT07057349
What this trial is testing

CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer

Who this might be right for
Metastatic CancerUnresectable Solid Tumor
Cytosite Biopharma Inc. 40
Very early researchStudy completedNCT05643248
What this trial is testing

To Assess Safety, Tolerability and PK of NEX-20A, a Subcutaneous Prolonged-release Injection to Healthy Subjects

Who this might be right for
Multiple Myeloma
Nanexa AB 9
Large-scale testing (Phase 3)WithdrawnNCT02539615
What this trial is testing

A Trial of the ForeCYTE Breast Aspirator for Cytological Testing of Nipple Aspirate Fluid in Women 30-55 Years Old

Who this might be right for
Breast Cancer, Preneoplastic Conditions, BRCA
Atossa Therapeutics, Inc.
Not applicableWithdrawnNCT07195617
What this trial is testing

Clinical Study on Evaluating the Safety and Effectiveness of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Third-line or Above Treatment

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Guangzhou Bio-gene Technology Co., Ltd
Not applicableStudy completedNCT06225414
What this trial is testing

Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)

Who this might be right for
Lung Cancer
University of California, Irvine 60
Large-scale testing (Phase 3)Study completedNCT00917306
What this trial is testing

A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)

Who this might be right for
Actinic Keratosis
Peplin 102
Not applicableUnknownNCT02726633
What this trial is testing

Evaluate the Utility of the ProLung China Test in the Diagnosis of Lung Cancer

Who this might be right for
Solitary Pulmonary NoduleMultiple Pulmonary Nodules
Chinese Alliance Against Lung Cancer 500
Testing effectiveness (Phase 2)Study completedNCT00002652
What this trial is testing

Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Arkansas
Not applicableStudy completedNCT00572338
What this trial is testing

Therapeutic Research in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 6,388
Not applicableUnknownNCT04947332
What this trial is testing

Auto-inoculation of a Wart in Multiple Viral Warts

Who this might be right for
Viral WartDelayed Hypersensitivity
Pak Emirates Military Hospital 80
Testing effectiveness (Phase 2)Study completedNCT02072863
What this trial is testing

Oprozomib, Melphalan, and Prednisone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Amgen 9
Testing effectiveness (Phase 2)Looking for participantsNCT06662006
What this trial is testing

Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer Patients

Who this might be right for
Advanced Metastatic Pancreatic Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 56
Not applicableEnded earlyNCT00253552
What this trial is testing

G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
OHSU Knight Cancer Institute 4
Not applicableUnknownNCT05606848
What this trial is testing

To Test the Food for Special Medical Purpose in Perioperative Patients With Gastrointestinal Cancer

Who this might be right for
Gastrointestinal Cancer
Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd 350
Early research (Phase 1)Study completedNCT02640755
What this trial is testing

Absorption, Metabolism, Excretion and Pharmacokinetics of a Single Dose [14C]AZD2014 Followed by a Multiple Dose Phase

Who this might be right for
Solid Malignancies
AstraZeneca 4
Early research (Phase 1)Not Yet RecruitingNCT07720843
What this trial is testing

TAlquetamab and BeLantamab Mafodotin in Relapsed/Refractory Multiple Myeloma (TaBleMM)

Who this might be right for
Relapse Multiple MyelomaRefractory Multiple Myeloma
Montefiore Medical Center 50
Large-scale testing (Phase 3)Active Not RecruitingNCT05943106
What this trial is testing

BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants

Who this might be right for
Non-Muscle- Invasive Bladder Cancer
AstraZeneca 100
Testing effectiveness (Phase 2)Study completedNCT00425204
What this trial is testing

Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment

Who this might be right for
Colorectal CancerNon-Small Cell Lung CancerProstate Cancer+2 more
Amgen 31
Testing effectiveness (Phase 2)Ended earlyNCT00664378
What this trial is testing

Efficacy Study of CYT997 in Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma
Gilead Sciences 5
Early research (Phase 1)Study completedNCT03602235
What this trial is testing

High Dose Ascorbic Acid for Plasma Cell Disorders

Who this might be right for
Multiple Myeloma
Christopher Strouse 6
Next Page